NCT00782249 is a NA clinical trial of Vagus nerve stimulation paradigm #1 in Epilepsy, sponsored by University Hospital, Ghent.

Who is sponsoring NCT00782249?

NCT00782249 is sponsored by University Hospital, Ghent.

What drugs are being tested in NCT00782249?

Interventions in NCT00782249: Vagus nerve stimulation paradigm #1, Vagus nerve stimulation paradigm #2, Vagus nerve stimulation paradigm #3.

Is NCT00782249 still recruiting?

NCT00782249 is currently completed. Last updated 16 February 2023.

Last reviewed 2023-02-16 · How we verify

NCT00782249

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Trial Comparing Different Stimulation Paradigms in Patients Treated With Vagus Nerve Stimulation for Refractory Epilepsy

Completed NA Last updated 16 February 2023

What this trial tests

NA trial testing Vagus nerve stimulation paradigm #1 in Epilepsy in 31 participants. Completed in 18 May 2009.

Timeline

28 September 2005

Primary endpoint
18 May 2009

18 May 2009

Quick facts

Lead sponsor	University Hospital, Ghent
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	31
Start date	28 September 2005
Primary completion	18 May 2009
Estimated completion	18 May 2009
Sites	2 locations across Belgium, United States

Drugs / interventions tested

Vagus nerve stimulation paradigm #1
Vagus nerve stimulation paradigm #2
Vagus nerve stimulation paradigm #3

Conditions studied

Epilepsy — all drugs for Epilepsy →

Sponsor

University Hospital, Ghent

Who can join

16 and older, any sex, with Epilepsy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients with refractory epilepsy who are candidates for a treatment with vagus nerve stimulation will be prospectively randomized into 3 arms with different vagus nerve stimulation paradigms. Vagus nerve stimulation parameters are programmed and adjusted during outpatient clinic visits, within the normal clinical practice.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Vagus nerve stimulation for partial seizures.
Panebianco M, Rigby A, Weston J, Marson AG. · · 2015 · cited 79× · PMID 25835947 · DOI 10.1002/14651858.cd002896.pub2
Vagus nerve stimulation for focal seizures.
Panebianco M, Rigby A, Marson AG. · · 2022 · cited 17× · PMID 35833911 · DOI 10.1002/14651858.cd002896.pub3

Verify or expand the search:

Other recruiting trials for Epilepsy

Currently open trials in the same condition.

NCT07095933 — The Safety and Efficacy Evaluation of Everolimus as an Adjunctive Treatment for Focal Refractory Epilepsy · EARLY_PHASE1 · recruiting
NCT07224191 — Hippocampal Oscillations During Exploration · NA · recruiting
NCT07219407 — A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures · Phase 2 · recruiting
NCT07417280 — LIFUS For Neurological Disorders · NA · recruiting
NCT07490769 — Levetiracetam Three Times Daily in Epilepsy · Phase 3 · recruiting

Other University Hospital, Ghent trials

Trials by the same sponsor.

NCT07584486 — Development of a New Simplified Tool to Predict LNPCPs Histology and Assess the Risk of Submucosal Invasive Cancer. The · NA · not yet recruiting
NCT07327450 — Coaching Doctors and Nurses to Improve Ethical Decision-making in Team · NA · not yet recruiting
NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
NCT07387328 — Validation of New sEMG Electrode Placement Guidelines for the Triceps Surae in Post-stroke Individuals. · not yet recruiting
NCT07237399 — Percutaneous Thermo-ablation for the Treatment of Prostate Cancer Oligometastatasis (TA-P-OLIM) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00782249 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Ghent
Last refreshed: 16 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00782249.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing